Howland Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-129,996
Closed -$12.9M 228
2019
Q3
$12.9M Sell
129,996
-12,230
-9% -$1.16M 0.98% 39
2019
Q2
$13.1M Sell
142,226
-45,398
-24% -$4.31M 1.02% 36
2019
Q1
$17.7M Buy
187,624
+894
+0.5% +$78.2K 1.44% 22
2018
Q4
$12M Sell
186,730
-51,547
-22% -$3.81M 1.13% 35
2018
Q3
$21.3M Buy
238,277
+10,411
+5% +$920K 1.62% 20
2018
Q2
$18.1M Sell
227,866
-2,005
-0.9% -$166K 1.44% 21
2018
Q1
$20.5M Buy
229,871
+29,068
+14% +$2.79M 1.65% 19
2017
Q4
$21M Buy
200,803
+43,950
+28% +$4.96M 1.68% 19
2017
Q3
$22.9M Buy
156,853
+12,455
+9% +$1.7M 1.89% 15
2017
Q2
$18.8M Buy
144,398
+6,682
+5% +$819K 1.59% 21
2017
Q1
$17.1M Buy
137,716
+32,188
+31% +$3.85M 1.48% 24
2016
Q4
$12.2M Buy
105,528
+28,791
+38% +$3.21M 1.14% 38
2016
Q3
$8.02M Buy
76,737
+74,512
+3,349% +$8.06M 0.75% 50
2016
Q2
$219K Buy
2,225
+64
+3% +$6.62K 0.02% 190
2016
Q1
$216K Buy
2,161
+111
+5% +$11.4K 0.02% 188
2015
Q4
$246K Hold
2,050
0.03% 180
2015
Q3
$222K Buy
2,050
+50
+3% +$6.21K 0.02% 182
2015
Q2
$231K Hold
2,000
0.02% 181
2015
Q1
$231K Hold
2,000
0.02% 184
2014
Q4
$224K Buy
+2,000
New +$211K 0.02% 188

Other funds holding CELG

Howland Capital Management's CELG Position: Q4 2019 in Review

Howland Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 129,996 shares — an estimated $12.9M sold.

Howland Capital Management first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $22.9M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Howland Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Howland Capital Management sold 129,996 Celgene Corp shares in Q4 2019, an estimated $12.9M.
  • Howland Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
  • Howland Capital Management's Celgene Corp position peaked at $22.9M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Howland Capital Management's 13F filing for Q4 2019, filed 23 Jan 2020.